Ordinary Adjustment | Solactive Global Health Services & Technology EMEA | Effective Date 21st January 2026
Solactive Global Health Services & Technology EMEA:
In the ordinary adjustment, the following composition will be implemented effective open 21st January 2026:
| ALCON INC |
| ALK-ABELLO A/S |
| ASTRAZENECA PLC |
| BIOMERIEUX |
| COLOPLAST AS CLASS B |
| CONVATEC GROUP PLC |
| DEMANT A/S |
| DR SULAIMAN AL HABIB MEDICAL SERVICES GROUP CO |
| FRESENIUS MEDICAL CARE AG & CO KGAA |
| FRESENIUS SE & CO KGAA |
| GALDERMA GROUP AG |
| GETINGE AB CLASS B |
| GRIFOLS SA CLASS A |
| GSK PLC |
| HALEON PLC |
| INTERNATIONAL HOLDINGS CO PJSC |
| IPSEN SA |
| KONINKLIJKE PHILIPS NV |
| LABORATORIOS FARMACEUTICOS R |
| LONZA GROUP AG |
| MIDDLE EAST HEALTHCARE COMPANY SJSC |
| MLP SAGLIK HIZMETLERI AS |
| MOUWASAT MEDICAL |
| NOVARTIS AG |
| ORION OYJ CLASS B |
| RECORDATI SPA |
| RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO RT |
| ROCHE HOLDING AG |
| SANDOZ GROUP AG |
| SANOFI SA |
| SIEGFRIED HOLDING AG-REG |
| SIEMENS HEALTHINEERS AG |
| SMITH & NEPHEW PLC |
| SONOVA HOLDING AG |
| SPECIALIZED MEDICAL ORD |
| SWEDISH ORPHAN BIOVITRUM AB |